The Neurodegenerative Disorder Therapeutics Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Neurodegenerative Disorder Therapeutics Market?
The global market report for Neurodegenerative Disorder Therapeutics for 2025 indicates a solid growth trend. The market size increased from $18.53 billion in 2024 to $20.04 billion in 2025, with a compound annual growth rate (CAGR) of 8.1%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Neurodegenerative Disorder Therapeutics Industry?
By 2029, the neurodegenerative disorder therapeutics market is predicted to have a market size of $28.33 billion, growing at a compound annual growth rate (CAGR) of 9.0%.
Download Your Free Sample of the 2025 Neurodegenerative Disorder Therapeutics Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Neurodegenerative Disorder Therapeutics Market?
The key drivers in the neurodegenerative disorder therapeutics market are:
• Rising demand for personalized and targeted medicine
• Increasing availability of clinical trials
• Growth in healthcare expenditure
• The introduction of disease-modifying therapies, non-pharmacological interventions, and digital health solutions.
Global Market Segmentation: Identifying Major Neurodegenerative Disorder Therapeutics Industry Segments
The neurodegenerative disorder therapeutics market covered in this report is segmented –
1) By Indication Type: Parkinson's Disease, Alzheimer's Disease, Multiple Sclerosis, Huntington Disease, Other Indication Types
2) By Drug Type: N- methyl- D- aspartate Receptor, Selective Serotonin Reuptake Inhibitor, Dopamine Inhibitors, Other Drug Types
3) By Distribution: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
Pre-order the 2025 Neurodegenerative Disorder Therapeutics Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Neurodegenerative Disorder Therapeutics Market?
The key trends in the neurodegenerative disorder therapeutics market are:
• The future of neurodegenerative disorder therapeutics is being increasingly shaped by disease-modifying therapies.
• The adoption of non-pharmacological interventions is a notable emerging trend.
• Telemedicine and remote monitoring program is gaining more attention.
• Technological innovations, precision therapeutics, digital health solutions and biomarker-driven trials are on the rise.
Who Are the Top Competitors & Leading Players in the Neurodegenerative Disorder Therapeutics Market?
Major companies in the neurodegenerative disorder therapeutics market are:
• Biogen Inc.
• Pfizer Inc.
• Novartis International AG
• Sanofi S.A.
• Teva Pharmaceutical Industries Ltd.
• UCB S.A.
• F. Hoffmann-La Roche Ltd.
• ACADIA Pharmaceuticals Inc.
• H. Lundbeck A/S
• Boehringer Ingelheim International GmbH
• Merck Serono S.A.
• Orion Corporation
• Mitsubishi Tanabe Pharma America
• Allergan PLC
• GlaxoSmithKline PLC
• AbbVie Inc.
• Eli Lilly and Company
• Celgene Corporation
• Neuro-Hitech Inc.
• Bayer Schering Pharma AG
• Amarin Corporation PLC
• AstraZeneca plc
• Alector Inc.
• Yumanity Therapeutics Inc.
• Yangtze River Pharmaceutical Group Co. Ltd.
• Chongqing Zein Pharmaceutical Co. Ltd.
• Eisai Co. Ltd.
• Bristol Myers Squibb Company
• AB Science S.A.
• Amylyx Pharmaceuticals Inc.
• Genentech Inc.
• GenSight Biologics S.A.
• AC Immune SA
• Annexon Bioscience Inc.
• BioArctic Neuroscience AB
• Cajal Neuroscience Inc.
• Cognito Therapeutics Inc.
• Grifols S.A.
• New Equilibrium Biosciences Inc.
• Prothena Corporation PLC
• Tessera Therapeutics Inc.
• Vigil Neuroscience Inc.
Regional Dominance: Which Area Leads the Global Neurodegenerative Disorder Therapeutics Market?
The countries covered in the neurodegenerative disorder therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada
